News

Share

Proposed regulation could put cancer therapies out of reach for patients on Medicare Part D plans

January 17, 2019

The administration has proposed a policy change to Medicare Part D that could have devastating consequences for cancer patients on Medicare.

These proposed changes could have wide-ranging impact as currently 43 million American seniors rely on Medicare Part D plans for their prescription drug coverage.

The proposed changes could allow the plans to:

  • Delay patient access to cutting edge cancer drugs
  • Overrule oncologists and deny coverage for a drug a doctor recommends

Cancer patients enrolled in Medicare Part D plans could be negatively affected by this proposed policy change as they could be denied coverage for lifesaving drugs.

Join us in asking Congress and the administration to protect cancer patients by stopping this proposed regulation.  We must do all we can to make prescription drugs more accessible and affordable for cancer patients.

Related Updates

June 17, 2022

Access Denied: The Injustice of the Medicaid Coverage Gap

The facts are clear: expanding access to Medicaid saves lives from cancer. Yet lawmakers in 12 states refuse to expand access to Medicaid for more than 2 million people who desperately need it. In fact, a new study led by researchers at the American Cancer Society shows the survival rate for people newly diagnosed with cancer is higher in states that have expanded Medicaid than in states that have not.

Read more
June 13, 2022

ACS CAN Volunteers Rally to Tell Congress that Affordable Cancer Care is Past Due

For ACS CAN volunteers nationwide, the past week has been packed with action – and with negotiations on an upcoming legislative package underway in Congress right now, it’s exactly the time to act. All the way from Maine to Arizona, ACS CAN volunteers hosted rallies and events throughout the country to let Congress know that affordable cancer is past due.

Read more